V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220611 | 20084016 | 1.9 | 1.22 | Palliative (P) | 2019-08-04 | 2019-08-04 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100124454 |
| 20220618 | 20084017 | 1.67 | 71.2 | Palliative (P) | 2019-09-21 | 2019-09-28 | Enzalutamide | 02 | N | ECF | 101201146 |
| 20220619 | 20084018 | 1.6 | null | null | 2016-07-16 | 2016-07-16 | Enzalutamide | 02 | null | CARBOPLATIN | 101491198 |
| 20220624 | 20084019 | 1.59 | 106.4 | Neo-adjuvant (N) | 2019-12-24 | 2019-12-26 | OCTREOTIDE | 02 | N | CETUXIMAB | 100526319 |
| 20220629 | 20084020 | 1.6 | 70 | Curative (C) | 2019-11-05 | 2019-11-12 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100821003 |
| 20220630 | 20084021 | 1.6 | 74 | Palliative (P) | 2019-05-21 | 2019-05-21 | Capecitabine + Cisplatin + RT | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101728578 |
| 20220633 | 20084022 | 1.75 | 69 | Palliative (P) | 2022-03-21 | 2022-04-04 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100598111 |
| 20220634 | 20084023 | 1.67 | 67 | Curative (C) | 2018-01-22 | 2018-02-02 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100122389 |
| 20220639 | 20084024 | 1.5 | 89.3 | Neo-adjuvant (N) | 2018-02-20 | 2018-02-22 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100749248 |
| 20220645 | 20084025 | 1.6 | 54.7 | 03 | 2019-04-12 | 2019-05-06 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100440436 |
| 20220647 | 20084026 | 1.65 | 71.4 | Neo-adjuvant (N) | null | 2017-03-05 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101503215 |
| 20220654 | 20084027 | 0 | 0 | 03 | 2018-12-12 | 2018-12-14 | Enzalutamide | 02 | Y | OXALIPLATIN + RALTITREXED | 100594997 |
| 20220655 | 20084028 | 1.8 | 92.4 | Adjuvant (A) | 2017-10-24 | 2017-10-31 | ECF | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101393971 |
| 20220656 | 20084029 | 1.66 | 77 | Neo-adjuvant (N) | 2018-09-13 | 2018-10-01 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101380641 |
| 20220657 | 20084030 | 1.82 | 75.6 | Palliative (P) | 2019-03-28 | 2019-03-30 | ECF | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100960000 |
| 20220666 | 20084031 | 1.64 | 98 | Curative (C) | 2019-11-24 | 2019-11-26 | Enzalutamide | 02 | Y | ATEZOLIZUMAB + BEVACIZUMAB | 100473181 |
| 20220667 | 20084032 | 1.7 | 70.3 | Neo-adjuvant (N) | 2018-05-22 | 2018-05-29 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100265977 |
| 20220670 | 20084033 | 1.67 | 68.7 | Curative (C) | 2017-09-03 | 2017-09-03 | Enzalutamide | null | Y | CARBOPLATIN + GEMCITABINE | 101639645 |
| 20220672 | 20084034 | 1.87 | 47.5 | Palliative (P) | 2018-02-04 | 2018-02-07 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 2 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100551328 |
| 20220673 | 20084035 | null | 77 | null | 2019-08-31 | 2019-09-13 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100161004 |
| 20220675 | 20084036 | 1.75 | 72.1 | Curative (C) | 2016-09-15 | 2016-09-15 | Enzalutamide | 99 | N | SCALOP-2 TRIAL | 100501279 |
| 20220679 | 20084037 | 1.86 | 81 | Palliative (P) | 2020-05-22 | 2020-05-22 | Enzalutamide | 02 | N | ECF | 101359202 |
| 20220681 | 20084038 | 1.71 | 128 | Curative (C) | 2016-12-04 | 2016-12-14 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100921109 |
| 20220682 | 20084039 | 1.7 | 85 | 03 | 2019-09-07 | 2019-09-15 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100950200 |
| 20220684 | 20084040 | 0 | 0 | Palliative (P) | null | 2020-11-08 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101029107 |
| 20220688 | 20084041 | 1.7 | 75.3 | Palliative (P) | 2018-10-10 | 2018-10-10 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + RT | 101281627 |
| 20220689 | 20084042 | 0 | 99 | Palliative (P) | 2016-01-18 | 2016-01-18 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100739337 |
| 20220690 | 20084043 | 1.57 | 64.3 | null | 2020-03-10 | 2020-03-19 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100147564 |
| 20220692 | 20084044 | 1.64 | 50 | Palliative (P) | 2016-10-12 | 2016-10-16 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101612881 |
| 20220693 | 20084045 | 1.63 | null | Palliative (P) | 2016-03-25 | 2016-07-04 | ATEZOLIZUMAB + BEVACIZUMAB | 2 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100463652 |
| 20220696 | 20084046 | 1.75 | null | Curative (C) | 2018-08-21 | 2018-08-22 | Enzalutamide | 2 | N | OCTREOTIDE | 101283040 |
| 20220697 | 20084047 | 1.62 | 47.7 | Palliative (P) | null | 2018-12-08 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100391345 |
| 20220698 | 20084048 | 1.8 | 65 | Neo-adjuvant (N) | 2017-12-04 | 2017-12-04 | Enzalutamide | 02 | N | CETUXIMAB | 101093615 |
| 20220701 | 20084049 | 0 | 0 | Not known (9) | 2020-10-25 | 2020-10-25 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100738318 |
| 20220702 | 20084050 | 1.6 | null | Palliative (P) | 2018-05-29 | 2018-06-15 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100871851 |
| 20220703 | 20084051 | 1.83 | 90 | Palliative (P) | null | 2018-03-26 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 100839860 |
| 20220704 | 20084052 | 1.59 | 96 | null | 2016-06-26 | 2016-07-10 | Carboplatin AUC 2 - 5 | 02 | null | ENZALUTAMIDE | 101792578 |
| 20220707 | 20084053 | 1.6 | 57.3 | Palliative (P) | 2018-05-02 | 2018-05-02 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101388201 |
| 20220713 | 20084054 | 1.61 | 74.1 | null | 2019-04-11 | 2019-04-18 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100301862 |
| 20220714 | 20084055 | 0 | 0 | Neo-adjuvant (N) | 2020-06-28 | 2020-07-03 | Enzalutamide | 02 | Y | CARBOPLATIN | 101248078 |
| 20220715 | 20084056 | 1.69 | 0 | Curative (C) | 2018-07-03 | 2018-07-17 | Enzalutamide | 02 | N | MITOMYCIN INTRAVESICULAR | 101790058 |
| 20220716 | 20084057 | 1.64 | 47.4 | Palliative (P) | 2017-07-26 | 2017-07-27 | Enzalutamide | N | N | SCALOP-2 TRIAL | 100539028 |
| 20220717 | 20084058 | 1.68 | 82.3 | Adjuvant (A) | 2017-10-29 | 2017-11-26 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101630203 |
| 20220727 | 20084059 | 1.7 | 94 | Palliative (P) | 2016-06-30 | 2016-06-30 | Enzalutamide | 02 | Y | ECF | 100768753 |
| 20220729 | 20084060 | 1.62 | 129 | Palliative (P) | 2019-03-20 | 2019-04-01 | Enzalutamide | 02 | N | OCTREOTIDE | 101476177 |
| 20220733 | 20084061 | 1.7 | 135 | Palliative (P) | 2016-11-13 | 2016-12-12 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100179600 |
| 20220736 | 20084062 | 1.62 | 47 | Palliative (P) | 2020-01-29 | 2020-01-30 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101793760 |
| 20220738 | 20084063 | 1.53 | 62.6 | Neo-adjuvant (N) | 2020-03-24 | 2020-03-26 | Cisplatin | N | Y | OXALIPLATIN + RALTITREXED | 100961355 |
| 20220743 | 20084064 | 1.59 | 74 | Curative (C) | 2017-05-22 | 2017-06-02 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101101804 |
| 20220745 | 20084065 | 1.68 | 41.2 | Curative (C) | 2019-02-16 | 2019-02-21 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100231340 |